Back to Results

A Phase 2 Study to Investigate the Safety and Efficacy of ABBV-105 and Upadacitinib Given Alone or in Combination (ABBV-599 Combination) in Subjects with Moderately to Severely Active Systemic Lupus Erythematosus

Study

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Barbara Davis Center
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Susan Boackle,  MD

Susan Boackle, MD

Study ID

Protocol Number: 19-1748

More information available at ClinicalTrials.gov: NCT03978520

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers